80

China Biotech Services Holdings LtdHKG 8037 Stock Report

Last reporting period 31 Dec, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.033

Micro

Exchange

XHKG - Hong Kong Exchange

8037.HK Stock Analysis

80

Uncovered

China Biotech Services Holdings Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

10/100

Low score

Market cap $B

0.033

Dividend yield

0.99 %

Shares outstanding

963.23 B

China Biotech Services Holdings Ltd. operates as an investment company, which engages in the provision of medical laboratory testing, and health check services. The company employs 295 full-time employees The company went IPO on 2004-06-17. The firm operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.

View Section: Eyestock Rating